loading page

What is Good for Hypertensive Patients: Presence or Absence of Presystolic Wave
  • +2
  • Gulay Uzun,
  • Dilek KIRCI,
  • Levent Korkmaz,
  • Ali Akyüz,
  • Muhammet Sayin
Gulay Uzun

Corresponding Author:[email protected]

Author Profile
Trabzon Kanuni Egitim ve Arastirma Hastanesi
Author Profile
Levent Korkmaz
Author Profile
Ali Akyüz
Akcaabat Hackali Baba State Hospital
Author Profile
Muhammet Sayin
Bulent Ecevit University
Author Profile


Background: The present study aimed at evaluating the feasibility of using presystolic wave as an indicator of early myocardial damage in patients with essential hypertension. Methods: The present study included 90 patients diagnosed with hypertension. The patients were divided into two groups on the basis of whether they exhibited the presence of PSW (n = 64, age: 56 ±11 years) or its absence (n = 26, age: 58 ±13 years), as revealed by the results of left ventricular outflow Doppler echocardiography. The levels of Heart-type free fatty acid-binding protein were compared between the two groups. Results: In the 90 hypertensive patients included in the present study, the prevalence of presystolic wave was determined to be 71%. The Heart-type free fatty acid-binding protein levels in the non-PSW patients were observed to be statistically higher than those in the PSW patients [4.88 ng/mL (2.82–17.83) vs. 3.99 ng/mL (2.57–17.87), p = 0.041]. Even though the ejection fractions and the left ventricular diameters were within the normal limits for the patients of both the groups, the value for the left ventricular end-diastolic diameter was observed to be statistically higher in the non-PSW group. No differences were observed in the mitral flow parameters between the two groups. Conclusion: The present study demonstrated that the absence of presystolic wave in the hypertensive patients with preserved left ventricular ejection fraction is an indicator of subclinical myocardial damage. The hypertensive patients exhibiting the absence of the presystolic wave should be strictly followed up for cardiac complications.